These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 3100307
21. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. Betteridge DJ, Bhatnager D, Bing RF, Durrington PN, Evans GR, Flax H, Jay RH, Lewis-Barned N, Mann J, Matthews DR. BMJ; 1992 May 23; 304(6838):1335-8. PubMed ID: 1611329 [Abstract] [Full Text] [Related]
24. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia. Mol MJ, Stuyt PM, Demacker PN, Stalenhoef AF. Neth J Med; 1990 Apr 23; 36(3-4):182-90. PubMed ID: 2355995 [Abstract] [Full Text] [Related]
25. Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study Group. Sun XM, Patel DD, Knight BL, Soutar AK. Atherosclerosis; 1998 Jan 23; 136(1):175-85. PubMed ID: 9544745 [Abstract] [Full Text] [Related]
26. The effect of cyclandelate on cholesterol metabolism in patients with familial hypercholesterolaemia. Gevers Leuven JA, vd Voort H, Kempen HJ, de Wit E, Havekes L. Drugs; 1987 Jan 23; 33 Suppl 2():131-5. PubMed ID: 3304952 [Abstract] [Full Text] [Related]
27. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia. Jones DB, Simpson HC, Slaughter P, Lousley S, Carter RD, Cobbe SM, Mann JI. Atherosclerosis; 1984 Oct 23; 53(1):1-7. PubMed ID: 6388586 [Abstract] [Full Text] [Related]
29. Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia. Wierzbicki AS, Lumb PJ, Cheung J, Crook MA. QJM; 1997 Oct 23; 90(10):631-4. PubMed ID: 9415344 [Abstract] [Full Text] [Related]
30. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia. Illingworth DR, Phillipson BE, Rapp JH, Connor WE. Lancet; 1981 Feb 07; 1(8215):296-8. PubMed ID: 6109940 [Abstract] [Full Text] [Related]
31. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination. Leitersdorf E, Muratti EN, Eliav O, Meiner V, Eisenberg S, Dann EJ, Sehayek E, Peters TK, Stein Y. Am J Med; 1994 May 07; 96(5):401-7. PubMed ID: 8192170 [Abstract] [Full Text] [Related]
33. Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia. Thompson GR, Ford J, Jenkinson M, Trayner I. Q J Med; 1986 Aug 07; 60(232):803-11. PubMed ID: 3640503 [Abstract] [Full Text] [Related]
38. Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia. Series JJ, Caslake MJ, Kilday C, Cruickshank A, Demant T, Lorimer AR, Packard CJ, Shepherd J. Metabolism; 1989 Feb 07; 38(2):153-8. PubMed ID: 2643751 [Abstract] [Full Text] [Related]
39. Hypolipidemic effect and mechanism of ketoconazole without and with cholestyramine in familial hypercholesterolemia. Gylling H, Vanhanen H, Miettinen TA. Metabolism; 1991 Jan 07; 40(1):35-41. PubMed ID: 1984567 [Abstract] [Full Text] [Related]